| Literature DB >> 26154022 |
Hema Umapathy1, Kim Bennell, Chris Dickson, Fiona Dobson, Marlene Fransen, Graeme Jones, David J Hunter.
Abstract
BACKGROUND: Despite the availability of evidence-based guidelines for conservative treatment of osteoarthritis (OA), management is often confined to the use of analgesics and waiting for eventual total joint replacement. This suggests a gap in knowledge for persons with OA regarding the many different treatments available to them.Entities:
Keywords: Internet; eHealth; osteoarthritis; quality of health care; self-care
Mesh:
Year: 2015 PMID: 26154022 PMCID: PMC4526979 DOI: 10.2196/jmir.4376
Source DB: PubMed Journal: J Med Internet Res ISSN: 1438-8871 Impact factor: 5.428
Demographic characteristics of participants at baseline (N=277).
| Characteristics | Baseline | Noncompleters | Nonusers | My Joint Pain users |
| |
| Age (years), mean (SD) | 61.0 (8.6) | 61.7 (8.5) | 60.9 (9.1) | 60.5 (8.3) | .64 | |
| Female, n (%) | 212 (76.5) | 60 (73) | 73 (80) | 79 (76.0) | .54 | |
| BMI (kg/m2), mean (SD) | 31.0 (6.8) | 30.4 (6.8) | 32.5 (10.0) | 30.4 (6.8) | .08 | |
|
|
|
|
|
| .20 | |
|
| Knee | 137 (49.4) | 45 (55) | 38 (42) | 54 (52.9) |
|
|
| Hip | 43 (15.5) | 7 (9) | 16 (18) | 20 (19.2) |
|
|
| Both | 92 (33.2) | 29 (35) | 34 (37) | 29 (27.9) |
|
a Total percentage may not add up as it was possible to receive a risk of OA without indicating a joint.
Mean within-group change between 12-month follow-up and baseline for each Health Evaluation Impact Questionnaire domain for users and nonusers of the My Joint Pain website.
| heiQ Domains | Users (n=104) | Nonusers ( n=91) | ||||
|
| Baseline score, mean (SD) | Mean difference (95% CI) |
| Baseline score, mean (SD) | Mean difference (95% CI) |
|
| 1. Health-directed activity | 2.78 (0.71) | 0.13 (0.03, 0.23) | .02 | 2.93 (0.68) | 0.02 (–0.10, 0.14) | .74 |
| 2. Positive and active engagement in life | 2.97 (0.56) | 0.11 (0.01, 0.20) | .03 | 3.10 (0.58) | 0.04 (–0.07, 0.15) | .44 |
| 3. Emotional distress | 2.58 (0.63) | 0.08 (–0.03, 0.20) | .16 | 2.60 (0.82) | 0.16 (0.04, 0.28) | .008 |
| 4. Self-monitoring and insight | 3.05 (0.35) | 0.10 (0.03, 0.17) | .01 | 3.12 (0.43) | 0.07 (–0.03, 0.17) | .19 |
| 5. Constructive attitudes and approaches | 2.99 (0.50) | 0.08 (–0.02, 0.17) | .12 | 3.06 (0.57) | 0.03 (–0.08, 0.14) | .58 |
| 6. Skill and technique acquisition | 2.69 (0.48) | 0.18 (0.07, 0.28) | .001 | 2.79 (0.49) | 0.07 (–0.05, 0.20) | .26 |
| 7. Social integration and support | 2.66 (0.50) | 0.10 (0.03, 0.18) | .006 | 2.64 (0.60) | 0.08 (–0.05, 0.20) | .25 |
| 8. Health service navigation | 2.84 (0.52) | 0.09 (–0.01, 0.18) | .07 | 2.98 (0.59) | 0.09 (–0.01, 0.19) | .07 |
Figure 1Mean change scores (standard error) between users and nonusers of the My Joint Pain website over a 12-month period for each Health Evaluation Impact Questionnaire domain.
Outcomes of the Osteoarthritis Quality Indicator at baseline and 12 months for users and nonusers of the My Joint Pain website.
| OAQI items | Users (n=104) | Nonusers (n=91) |
| ||||
|
| Baseline, eligible (pass rate)a | 12-month follow-up, eligible (pass rate)a |
| Baseline, eligible (pass rate)a | 12-month follow-up, eligible (pass rate)a |
|
|
| 1. Disease development | 99 (56) | 95 (68) | .65 | 81 (53) | 81 (59) | .43 | .51 |
| 2. Treatment alternatives | 99 (62) | 100 (65) | .62 | 88 (52) | 86 (56) | .64 | .80 |
| 3. Self-management | 99 (53) | 99 (68) | .03 | 88 (47) | 87 (48) | .82 | .001 |
| 4. Lifestyle | 99 (53) | 99 (69) | .02 | 89 (48) | 90 (53) | .50 | .36 |
| 5. Physical activity | 103 (77) | 104 (88) | .04 | 90 (79) | 91 (86) | .23 | .79 |
| 6. Referral physical activity | 104 (51) | 103 (62) | .11 | 90 (53) | 89 (57) | .59 | .37 |
| 7. Weight reduction | 74 (69) | 70 (71) | .74 | 64 (83) | 64 (77) | .38 | .03 |
| 8. Referral weight reduction | 68 (18) | 66 (24) | .35 | 64 (25) | 57 (39) | .11 | .95 |
| 9. Functional assessment | 89 (47) | 76 (50) | .72 | 76 (45) | 76 (51) | .42 | .40 |
| 10. Walking aid assessment | 68 (26) | 65 (38) | .14 | 64 (31) | 59 (36) | .61 | .22 |
| 11. Other aids assessment | 55 (15) | 55 (18) | .61 | 58 (17) | 51 (27) | .20 | .80 |
| 12. Pain assessment | 103 (64) | 100 (67) | .66 | 91 (62) | 88 (53) | .27 | .37 |
| 13. Acetaminophen | 104 (76) | 103 (81) | .42 | 91 (79) | 89 (79) | .94 | .71 |
| 14. Stronger pain killers | 94 (62) | 92 (67) | .42 | 80 (59) | 75 (52) | .40 | .62 |
| 15. NSAIDs | 83 (78) | 83 (76) | .71 | 64 (77) | 55 (80) | .65 | .41 |
| 16. Cortisone | 84 (49) | 81 (42) | .38 | 73 (55) | 59 (47) | .40 | .06 |
| 17. Referral to orthopedic surgeons | 73 (53) | 81 (58) | .57 | 66 (52) | 59 (53) | .91 | .29 |
a Number of eligible persons calculated as total number of yes and no answers and who did not provide not applicable or “do not remember” answers. Pass rates are the proportion of yes answers over the number of eligible.